Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives

Details for Australian Patent Application No. 2004218249 (hide)

Owner Mitsubishi Pharma Corporation Sanofi-Aventis

Inventors Lochead, Alistair; Slowinski, Franck; Yaiche, Philippe; Saady, Mourad

Agent Davies Collison Cave

Pub. Number AU-B-2004218249

PCT Pub. Number WO2004/078759

Priority 03290571.3 07.03.03 EP; 03290570.5 07.03.03 EP

Filing date 5 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 30 April 2009

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078759 Priority application(s): WO2004/078759

30 April 2009 Application Accepted

  Published as AU-B-2004218249

27 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218250-Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyri mido [1,2-a] pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-p yrimido (1,2-a) pyrimidin-6-one derivatives and their use against neurogenerative diseases

2004218242-Pigment preparation and method for producing the same